Skip to main content
Ingredients/Compound/Inosinic acid

Inosinic acid.

Strength pending.The research strength is not set yet.

This is the savoury booster in aged meat, dried fish and seasoning blends. On its own it barely tastes of anything. Its job is amplifying the umami of glutamate.

IACompound
Inosinic acidIngredientMD
Category
Compound

What Inosinic acid is, and what it does.

Does it work
It suits food formulators wanting savoury depth at lower sodium. As a supplement for a body process there is no established role, since your body builds its own purines.
How much to take
No supplemental daily amount is on record. In food it is used in fractions of a percent, which is enough because the effect works alongside glutamate rather than alone.
Time to feel it
Instantly, on the tongue. Savoury depth arrives with the mouthful, and there is no delayed effect to wait on.
The first dose
Food tastes rounder and more savoury. Nothing else about day one is noticeable, and no body-level change has been measured at food amounts.
With regular use
Weeks of regular intake mainly mean a steady small purine load, which ends as urate because humans lack uricase. That shows on a blood panel, not in how you feel.
How well tolerated
Well tolerated as a food additive. Because it adds to the purine pool, people keeping an eye on their urate levels usually keep purine-rich seasonings modest.
How it feels
A mouth-filling savoury roundness, the quality people call brothy. It shows up in taste rather than anywhere in the body.
The overlooked benefit
It is the branch point of purine synthesis: every adenine and guanine nucleotide in your cells is built from inosinate, so it sits upstream of both DNA and ATP.

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

  • umami potentiation alongside glutamate at the T1R1 and T1R3 receptorNarrative review
  • hydrolysis of ingested nucleotides before absorptionNarrative review
  • contribution of dietary purine intake to the urate poolCohort study
  • accumulation in muscle after slaughter as ATP breaks downNarrative review
  • savoury seasoning and food appeal when appetite is lowRandomised trial
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.
Pairs well with5 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

Inosinic acid + SodiumEstablished sensory work on salt reduction using ribonucleotides.

Adding inosinate lets a formulator hold perceived savouriness while cutting added salt, because umami intensity partly substitutes for the sensation salt provides. The compound itself is supplied as a sodium salt, so it contributes a small amount of sodium back. Net sodium usually still falls because the substitution ratio is favourable. This is a formulation lever, not a physiological effect.

Inosinic acid + MolybdenumEstablished enzymology of xanthine oxidoreductase.

Inosinate is a purine nucleotide, and its breakdown runs through hypoxanthine and xanthine to urate. Xanthine oxidoreductase, the enzyme that catalyses both of those steps, carries a molybdenum cofactor. Without adequate molybdenum the enzyme cannot function, which is textbook biochemistry rather than a supplement interaction. Dietary molybdenum deficiency is rare in people eating ordinary food.

Inosinic acid + Vitamin CEstablished renal handling of urate. Vitamin C acts on tubular urate reabsorption.

Ascorbate competes with urate at the URAT1 transporter in the kidney tubule, which increases urate excretion and modestly lowers serum urate. Since inosinate is a dietary purine that ends in urate, the two act in opposite directions on the same pool. The size of the vitamin C effect is small. It is a directional point about shared handling, not a strategy.

Inosinic acid + D-RiboseEstablished de novo purine biosynthesis.

Inosinate is the first complete purine nucleotide the body builds, and it is assembled on a ribose-5-phosphate backbone supplied as PRPP from the pentose phosphate pathway. Ribose feeds that pool. Every adenine and guanine nucleotide in the body is made downstream of inosine monophosphate, which is why this molecule sits at the branch point of purine synthesis.

Inosinic acid + Creatine monohydrateEstablished muscle energetics of the purine nucleotide cycle.

During hard contraction, when ATP resynthesis falls behind, adenylate kinase and AMP deaminase push AMP toward inosine monophosphate, and muscle inosinate rises. Phosphocreatine buffers ATP during exactly those first seconds, so a well-loaded creatine pool blunts the drop that drives that reaction. The relationship is about intramuscular nucleotide handling and does not imply that swallowing inosinate does anything for exercise.

Who should be cautious

Nothing specific on file for Inosinic acid. Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What Inosinic acid actually does.

Established

It is the shared parent molecule the body builds both of its purine building blocks from.

Established

You do not absorb it whole. It gets taken apart in the gut like any other nucleotide.

Established

Purines in food end up as uric acid. Humans cannot break it down further.

Established

The savoury punch in aged meat and dried bonito flakes is largely this compound, formed after the fact.

More than one route, 6 steps on record

Where Inosinic acid comes from.

It is the savoury compound that builds up in aged meat and dried fish. Industry makes it by fermenting sugar or by breaking down yeast RNA.

The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.

Starts as
Glucose from starch, or yeast biomass, or RNA-rich fish and meat tissue

Three separate industrial routes exist. The dominant one starts from a sugar feedstock. The others start from yeast RNA or from naturally nucleotide-rich animal tissue.

Converted by
Bacterial fermentation or enzymatic RNA hydrolysis

Engineered Corynebacterium or Bacillus strains accumulate inosine or inosinate directly from sugar. The alternative route uses 5'-phosphodiesterase to cut yeast RNA into its four constituent nucleotides, from which inosinate is separated.

Extracted by
Broth clarification

Cells and solids are filtered off and the nucleotide-bearing liquor is concentrated.

Purified by
Ion exchange and crystallisation

Ion exchange chromatography separates inosinate from guanylate and other nucleotides, followed by crystallisation of the salt.

Standardised to
Assay and salt adjustment

Purity assayed by HPLC and the counter-ion set as sodium, potassium or calcium.

Ends up as
Crystalline salt or blend

Dried, milled and either sold as the single salt or blended with disodium guanylate.

Getting Inosinic acid from food.

The whole-food sources on file. A supplement closes the gap, it does not replace dinner.

Dried bonito flakesDried sardinesPork loinChicken thighBeef

A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.

The forms it comes in.

Disodium inosinate, E631Disodium salt of inosine monophosphate, freely water soluble, supplied as a crystalline powderFits Savoury seasoning, stocks, snack coatings and salt-reduction work, where it is nearly always paired with a glutamate sourceTrade-off Contributes sodium, and it is a purine, so people managing urate intake count it with other purine sources
Dipotassium inosinatePotassium counter-ion in place of sodium, similar solubilityFits Reduced-sodium formulations where the sodium contributed by the salt itself mattersTrade-off Carries a slight metallic or bitter note at higher use levels, and adds potassium, which is relevant for anyone with restricted potassium intake
Calcium inosinateDivalent counter-ion, lower water solubility than the sodium saltFits Dry blends where hygroscopicity is a problem and where neither sodium nor potassium is wantedTrade-off Slower to dissolve, so it suits dry applications more than clear liquid systems
Disodium inosinate and disodium guanylate, E635Fixed blend of the two ribonucleotide salts, typically near equal partsFits General savoury seasoning where a broader umami character is wanted from one ingredientTrade-off The label declares a blend rather than the individual compounds, so the exact inosinate figure is not visible to the buyer
What the strongest studies found

The essence, in one line each.

  1. Dietary polyphenol supplementation changed muscle flavour nucleotide and amino acid profiles, inosinic acid among them, in the treated animals.Animal study. Xu X et al., 2019 (Food and Function). PMID 31660546
  2. Coated sodium butyrate in feed was followed by changes in meat quality indices including muscle inosinic acid content.Animal study. Gu Z et al., 2025 (Genes). PMID 40282393

These are the studies our verdict leans on, chosen from the 2 we read for Inosinic acid. The full linked list is below.

Primary evidence

The studies, linked.

1 source behind our Inosinic acid verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.

  1. ClinicalTrials.gov

Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.

Side effects reported to the FDA

Problems people have reported.

Read this carefully. These are 28 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Inosinic acid is, not how risky it is. A report is not proof Inosinic acid caused anything. It is a signal of what to watch for, nothing more.

Alanine Aminotransferase Increased
2
Anaemia
2
Constipation
2
Erythema Multiforme
2
Hypoalbuminaemia
2
Hypocalcaemia
2

Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.